Cardiff Oncology
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $104 | $41 | $243 | $120 |
Gross Profit | 104 | 41 | 243 | 120 |
EBITDA | -9,058 | -12,124 | -6,993 | -10,764 |
EBIT | -9,232 | -12,345 | -7,216 | -11,258 |
Net Income | -9,232 | -12,345 | -7,216 | -11,258 |
Net Change In Cash | 104 | 41 | 243 | 120 |
Free Cash Flow | -11,809 | -12,288 | -5,967 | -10,852 |
Cash | 9,197 | 8,544 | 17,470 | 10,135 |
Basic Shares | 68,397 | 68,350 | 66,841 | 66,879 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $593 | $683 | $488 | $386 |
Gross Profit | 593 | 683 | 488 | 386 |
EBITDA | -44,947 | -45,027 | -41,043 | -38,468 |
EBIT | -45,851 | -45,431 | -41,441 | -38,704 |
Net Income | -45,851 | -45,431 | -41,441 | -38,704 |
Net Change In Cash | 593 | 683 | 488 | 386 |
Cost of Revenue | 4,404 | |||
Free Cash Flow | -37,967 | -37,773 | -31,469 | -34,712 |
Cash | 17,470 | 51,470 | 21,655 | 16,347 |
Basic Shares | 66,841 | 47,650 | 44,677 | 43,600 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.14 |
2026-03-31 | -$0.18 |
2025-12-31 | -$0.11 |
2025-09-30 | -$0.17 |